RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
84 hedge funds and large institutions have $382M invested in Rubius Therapeutics, Inc in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 32 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
25% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 32
Holders
84
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$1.26M | |
| 2 | +$547K | |
| 3 | +$248K | |
| 4 |
HF
HRT Financial
New York
|
+$230K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$195K |
Top Sellers
| 1 | -$3.96M | |
| 2 | -$1.76M | |
| 3 | -$1.07M | |
| 4 |
Morgan Stanley
New York
|
-$979K |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$933K |